Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Zhong Yuan BioTechnology Holdings Ltd (QB) | ZHYBF | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.24 | 5.24 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 1.47 - 6.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 5.24 | USD |
Zhong Yuan BioTechnology Holdings Ltd (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 92.64M | 17.68M | 2.13M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Zhong Yuan BioTechnology (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZHYBF Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 6.50 | 6.50 | 5.24 | 5.63 | 110 | -1.26 | -19.38% |
3 Months | 5.50 | 6.50 | 3.50 | 5.04 | 290 | -0.26 | -4.73% |
6 Months | 2.03 | 6.50 | 1.47 | 4.67 | 524 | 3.21 | 158.13% |
1 Year | 4.48 | 6.50 | 1.47 | 4.72 | 635 | 0.76 | 16.96% |
3 Years | 0.51 | 7.59 | 0.2253 | 4.36 | 2,447 | 4.73 | 927.45% |
5 Years | 0.51 | 7.59 | 0.2253 | 4.36 | 2,447 | 4.73 | 927.45% |
Zhong Yuan BioTechnology (QB) Description
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED is mainly engaged in the brain health research, develop products and sales of plant-derived Nervonic Acid which is a widely accepted effective agent for pharmaceutical and nutraceutical applications in the prevention and treatment of neurological disorder and associated diseases including Alzheimers disease. ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED was established in 2012 and the company cumulates the top raw material of Nervonic acid, it is engaged in the R&D of the medicine for neuroscience. Currently the patented Category III medical device: Cognitive Impairment Diagnosis Early Screening Kit is in the phrase of pre-clinical trial. The company devotes itself to build research & development engine for new medicine of new target and new mechanism. |